Table of Contents
1 Market Overview
1.1 Recombinant Human Endostatin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Recombinant Human Endostatin Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Purity:95%
1.2.3 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Recombinant Human Endostatin Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Medical Care
1.3.3 Scientific Research
1.3.4 Others
1.4 Overview of Global Recombinant Human Endostatin Market
1.4.1 Global Recombinant Human Endostatin Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Thermo Fisher Scientific SWOT Analysis
2.1.4 Thermo Fisher Scientific Product and Services
2.1.5 Thermo Fisher Scientific Recombinant Human Endostatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 ELISA
2.2.1 ELISA Details
2.2.2 ELISA Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 ELISA SWOT Analysis
2.2.4 ELISA Product and Services
2.2.5 ELISA Recombinant Human Endostatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Recombinant Human Endostatin Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Recombinant Human Endostatin Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Recombinant Human Endostatin Manufacturer Market Share in 2019
3.3.2 Top 6 Recombinant Human Endostatin Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Recombinant Human Endostatin Sales, Revenue and Market Share by Regions
4.1.1 Global Recombinant Human Endostatin Sales and Market Share by Regions (2015-2020)
4.1.2 Global Recombinant Human Endostatin Revenue and Market Share by Regions (2015-2020)
4.2 North America Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
4.3 Europe Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
4.5 South America Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Recombinant Human Endostatin Sales, Revenue and Market Share by Country
5.1.1 North America Recombinant Human Endostatin Sales and Market Share by Country (2015-2020)
5.1.2 North America Recombinant Human Endostatin Revenue and Market Share by Country (2015-2020)
5.2 United States Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
5.3 Canada Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
5.4 Mexico Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Recombinant Human Endostatin Sales, Revenue and Market Share by Country
6.1.1 Europe Recombinant Human Endostatin Sales and Market Share by Country (2015-2020)
6.1.2 Europe Recombinant Human Endostatin Revenue and Market Share by Country (2015-2020)
6.2 Germany Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
6.3 UK Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
6.4 France Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
6.5 Russia Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
6.6 Italy Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Recombinant Human Endostatin Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Recombinant Human Endostatin Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Recombinant Human Endostatin Revenue and Market Share by Regions (2015-2020)
7.2 China Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
7.3 Japan Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
7.4 Korea Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
7.5 India Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
7.7 Australia Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Recombinant Human Endostatin Sales, Revenue and Market Share by Country
8.1.1 South America Recombinant Human Endostatin Sales and Market Share by Country (2015-2020)
8.1.2 South America Recombinant Human Endostatin Revenue and Market Share by Country (2015-2020)
8.2 Brazil Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
8.3 Argentina Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Recombinant Human Endostatin Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Recombinant Human Endostatin Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Recombinant Human Endostatin Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
9.3 Turkey Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
9.4 Egypt Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
9.5 South Africa Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Recombinant Human Endostatin Sales and Market Share by Type (2015-2020)
10.2 Global Recombinant Human Endostatin Revenue and Market Share by Type (2015-2020)
10.3 Global Recombinant Human Endostatin Price by Type (2015-2020)
11 Global Recombinant Human Endostatin Market Segment by Application
11.1 Global Recombinant Human Endostatin Sales Market Share by Application (2015-2020)
11.2 Global Recombinant Human Endostatin Revenue Market Share by Application (2015-2020)
11.3 Global Recombinant Human Endostatin Price by Application (2015-2020)
12 Market Forecast
12.1 Global Recombinant Human Endostatin Sales, Revenue and Growth Rate (2021-2025)
12.2 Recombinant Human Endostatin Market Forecast by Regions (2021-2025)
12.2.1 North America Recombinant Human Endostatin Market Forecast (2021-2025)
12.2.2 Europe Recombinant Human Endostatin Market Forecast (2021-2025)
12.2.3 Asia-Pacific Recombinant Human Endostatin Market Forecast (2021-2025)
12.2.4 South America Recombinant Human Endostatin Market Forecast (2021-2025)
12.2.5 Middle East & Africa Recombinant Human Endostatin Market Forecast (2021-2025)
12.3 Recombinant Human Endostatin Market Forecast by Type (2021-2025)
12.3.1 Global Recombinant Human Endostatin Sales Forecast by Type (2021-2025)
12.3.2 Global Recombinant Human Endostatin Market Share Forecast by Type (2021-2025)
12.4 Recombinant Human Endostatin Market Forecast by Application (2021-2025)
12.4.1 Global Recombinant Human Endostatin Sales Forecast by Application (2021-2025)
12.4.2 Global Recombinant Human Endostatin Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Recombinant Human Endostatin Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Recombinant Human Endostatin by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Recombinant Human Endostatin Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 8. Thermo Fisher Scientific Recombinant Human Endostatin Major Business
Table 9. Thermo Fisher Scientific Recombinant Human Endostatin Total Revenue (USD Million) (2018-2019)
Table 10. Thermo Fisher Scientific SWOT Analysis
Table 11. Thermo Fisher Scientific Recombinant Human Endostatin Product and Services
Table 12. Thermo Fisher Scientific Recombinant Human Endostatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. ELISA Basic Information, Manufacturing Base and Competitors
Table 14. ELISA Recombinant Human Endostatin Major Business
Table 15. ELISA Recombinant Human Endostatin Total Revenue (USD Million) (2018-2019)
Table 16. ELISA SWOT Analysis
Table 17. ELISA Recombinant Human Endostatin Product and Services
Table 18. ELISA Recombinant Human Endostatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Global Recombinant Human Endostatin Sales by Manufacturer (2018-2019) (MT)
Table 20. Global Recombinant Human Endostatin Revenue by Manufacturer (2018-2019) (USD Million)
Table 21. Global Recombinant Human Endostatin Sales by Regions (2015-2020) (MT)
Table 22. Global Recombinant Human Endostatin Sales Market Share by Regions (2015-2020)
Table 23. Global Recombinant Human Endostatin Revenue by Regions (2015-2020) (USD Million)
Table 24. North America Recombinant Human Endostatin Sales by Countries (2015-2020) (MT)
Table 25. North America Recombinant Human Endostatin Sales Market Share by Countries (2015-2020)
Table 26. North America Recombinant Human Endostatin Revenue by Countries (2015-2020) (USD Million)
Table 27. North America Recombinant Human Endostatin Revenue Market Share by Countries (2015-2020)
Table 28. Europe Recombinant Human Endostatin Sales by Countries (2015-2020) (MT)
Table 29. Europe Recombinant Human Endostatin Sales Market Share by Countries (2015-2020)
Table 30. Europe Recombinant Human Endostatin Revenue by Countries (2015-2020) (USD Million)
Table 31. Asia-Pacific Recombinant Human Endostatin Sales by Regions (2015-2020) (MT)
Table 32. Asia-Pacific Recombinant Human Endostatin Sales Market Share by Regions (2015-2020)
Table 33. Asia-Pacific Recombinant Human Endostatin Revenue by Regions (2015-2020) (USD Million)
Table 34. South America Recombinant Human Endostatin Sales by Countries (2015-2020) (MT)
Table 35. South America Recombinant Human Endostatin Sales Market Share by Countries (2015-2020)
Table 36. South America Recombinant Human Endostatin Revenue by Countries (2015-2020) (USD Million)
Table 37. South America Recombinant Human Endostatin Revenue Market Share by Countries (2015-2020)
Table 38. Middle East & Africa Recombinant Human Endostatin Sales by Countries (2015-2020) (MT)
Table 39. Middle East & Africa Recombinant Human Endostatin Sales Market Share by Countries (2015-2020)
Table 40. Middle East & Africa Recombinant Human Endostatin Revenue by Countries (2015-2020) (USD Million)
Table 41. Middle East & Africa Recombinant Human Endostatin Revenue Market Share by Countries (2015-2020)
Table 42. Global Recombinant Human Endostatin Sales by Type (2015-2020) (MT)
Table 43. Global Recombinant Human Endostatin Sales Share by Type (2015-2020)
Table 44. Global Recombinant Human Endostatin Revenue by Type (2015-2020) (USD Million)
Table 45. Global Recombinant Human Endostatin Revenue Share by Type (2015-2020)
Table 46. Global Recombinant Human Endostatin Sales by Application (2015-2020) (MT)
Table 47. Global Recombinant Human Endostatin Sales Share by Application (2015-2020)
Table 48. Global Recombinant Human Endostatin Sales Forecast by Regions (2021-2025) (MT)
Table 49. Global Recombinant Human Endostatin Market Share Forecast by Regions (2021-2025)
Table 50. Global Recombinant Human Endostatin Sales Forecast by Type (2021-2025) (MT)
Table 51. Global Recombinant Human Endostatin Market Share Forecast by Type (2021-2025)
Table 52. Global Recombinant Human Endostatin Sales Forecast by Application (2021-2025)
Table 53. Global Recombinant Human Endostatin Market Share Forecast by Application (2021-2025)
Table 54. Direct Channel Pros & Cons
Table 55. Indirect Channel Pros & Cons
Table 56. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Recombinant Human Endostatin Picture
Figure 2. Global Sales Market Share of Recombinant Human Endostatin by Type in 2019
Figure 3. Purity:95% Picture
Figure 4. Others Picture
Figure 5. Recombinant Human Endostatin Sales Market Share by Application in 2018
Figure 6. Medical Care Picture
Figure 7. Scientific Research Picture
Figure 8. Others Picture
Figure 9. Global Recombinant Human Endostatin Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Recombinant Human Endostatin Sales Market Share by Manufacturer in 2019
Figure 30. Global Recombinant Human Endostatin Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Recombinant Human Endostatin Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Recombinant Human Endostatin Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 35. Global Recombinant Human Endostatin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Recombinant Human Endostatin Revenue Market Share by Regions (2015-2020)
Figure 37. Global Recombinant Human Endostatin Revenue Market Share by Regions in 2018
Figure 38. North America Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
Figure 39. Europe Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
Figure 41. South America Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
Figure 43. North America Recombinant Human Endostatin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Recombinant Human Endostatin Sales Market Share by Countries (2015-2020)
Figure 45. North America Recombinant Human Endostatin Sales Market Share by Countries in 2018
Figure 46. North America Recombinant Human Endostatin Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Recombinant Human Endostatin Revenue Market Share by Countries in 2018
Figure 48. United States Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 49. Canada Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 50. Mexico Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 51. Europe Recombinant Human Endostatin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Recombinant Human Endostatin Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Recombinant Human Endostatin Revenue Market Share by Countries in 2019
Figure 54. Germany Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 55. UK Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 56. France Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 57. Russia Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 58. Italy Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 59. Asia-Pacific Recombinant Human Endostatin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Recombinant Human Endostatin Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Recombinant Human Endostatin Revenue Market Share by Regions 2019
Figure 62. China Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 63. Japan Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 64. Korea Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 65. India Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 66. Southeast Asia Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 67. South America Recombinant Human Endostatin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Recombinant Human Endostatin Sales Market Share by Countries in 2019
Figure 69. South America Recombinant Human Endostatin Revenue Market Share by Countries in 2019
Figure 70. Brazil Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 71. Argentina Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 72. Middle East and Africa Recombinant Human Endostatin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Recombinant Human Endostatin Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Recombinant Human Endostatin Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Recombinant Human Endostatin Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 77. Egypt Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 78. Turkey Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 79. South Africa Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 80. Global Recombinant Human Endostatin Sales and Growth Rate (2021-2025) (MT)
Figure 81. Global Recombinant Human Endostatin Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Recombinant Human Endostatin Market Forecast (2021-2025) (MT)
Figure 83. Europe Sales Recombinant Human Endostatin Market Forecast (2021-2025) (MT)
Figure 84. Asia-Pacific Sales Recombinant Human Endostatin Market Forecast (2021-2025) (MT)
Figure 85. South America Sales Recombinant Human Endostatin Market Forecast (2021-2025) (MT)
Figure 86. Middle East & Africa Sales Recombinant Human Endostatin Market Forecast (2021-2025) (MT)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
【掲載企業】
Thermo Fisher Scientific、ELISA